VICR Community Comments: IP, Litigation, and Royalty Reality Check

Summary

Vicor's IP and royalty thesis is credible, but narrower than the most bullish community commentary suggests.Supported: AI accelerators are making last-inch power delivery more important; Vicor owns differentiated architecture and packaging IP; it has successfully enforced two patents at the ITC; and royalty revenue is now material and growing.Not established: universal protection against competing designs, victory in the pending 2026 case, the identity of unnamed licensees or customers, and community estimates of hundreds of millions or billions of dollars of near-term royalties.> Bottom line: Vicor has commercially validated, stronger-than-average IP protection—not an impregnable monopoly. Its royalties are recurring in part, but Q2 2026 should not yet be treated as a durable quarterly run rate.

Community claim check

Litigation and IP strength

Evidence supporting the moat

In ITC investigation 337-TA-1370, Vicor established a Section 337 violation involving Patents 9,166,481 and 9,516,761. The ITC issued a limited exclusion order against covered unlicensed imports and cease-and-desist orders against several respondents. Vicor also satisfied the ITC domestic-industry requirements for those two patents.Delta sought inter partes review of the `’481`, `’761`, and `’950` patents. The PTAB denied institution after finding that the petitions did not show the required likelihood of success on the claims remaining at issue. That is meaningful evidence of resilience, although not a universal validity judgment covering Vicor's entire portfolio.

Boundaries and adverse evidence

The first ITC result was mixed. Certain products did not infringe, the `’950` patent produced no violation, and some respondents possessed a license to the `’761` patent.The current 337-TA-1484 case concerning Patent 12,395,087 could expand the demonstrated perimeter of Vicor's protection. For now it remains a pending allegation.Enforcement also runs both ways. After losing separate SynQor litigation, Vicor paid $28.6M in March 2026. That does not invalidate Vicor's patents, but it demonstrates overlapping patent estates and meaningful litigation costs.

Are royalties recurring?

Vicor's normal royalty model has recurring characteristics: royalties are generally a percentage of licensee sales and are recognized as covered sales or usage occurs.However, some licenses use minimum expected payments or recognize revenue upon payment. Reported royalty revenue may therefore combine recurring usage, minimums, catch-up amounts, and timing effects.The attractive long-term outcome is a protected ecosystem in which Vicor earns high-incremental-margin royalties from second sources while also selling its own products. The principal risks are contract opacity, licensee concentration, design-arounds, patent expiration, and licensing economics that displace product revenue.

Conclusion

The record supports underwriting Vicor's existing royalty base and the two adjudicated patents. It does not support assuming success in the new litigation, naming undisclosed hyperscaler customers, or capitalizing Q2 royalties as a permanent annuity.The next useful proof points are Q3–Q4 royalty persistence, disclosure about the new license's economic structure, progress in 337-TA-1484, and evidence that VPD is moving into repeatable high-volume accelerator platforms.

Primary sources

• Vicor Q2 2026 Form 10-Q
• Vicor 2025 Form 10-K
• USITC final determination, 337-TA-1370
• USITC institution notice, 337-TA-1484